Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas. 2006

Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
Telemark University College, Faculty of Arts and Sciences, Hallvard Eikas plass, 3800 Bø i Telemark, Norway. mona.sabo@hit.no

BACKGROUND The association between colorectal cancer (CRC) and smoking has not been consistent. Incomplete smoking history and association to a specific subset of CRC tumors have been proposed as explanations. The adenomatous polyposis coli (APC) gene has been reported to have a "gatekeeper" function in the colonic mucosa. METHODS To evaluate the hypothesis that cigarette smoking is associated with adenoma and carcinoma development and further to investigate whether this association is due to mutations in the APC gene, we used a study population consisting of 133 cases (45 adenomas and 88 carcinomas) and 334 controls. All tumors were sequenced in the mutation cluster region (MCR) of the APC gene. Cases and controls were drawn from a homogeneous cohort of Norwegian origin. RESULTS The mutational spectra of the APC gene revealed no difference in frequencies of mutations in cases based on ever and never smoking status. An overall case-control association was detected for adenomas and "ever smoking" OR = 1.73 (95% CI 0.83-3.58). For CRC cases several smoking parameters for dose and duration were used. We detected an association for all smoking parameters and "duration of smoking > 30 years", yielded a statistically significant OR = 2.86 (1.06-7.7). When cases were divided based on APC truncation mutation status, an association was detected in adenomas without APC mutation in relation to "ever smoking", with an OR = 3.97 (1.26-12.51). For CRC cases without APC mutation "duration of smoking > 30 years", yielded a statistically significant OR = 4.06 (1.20-13.7). The smoking parameter "starting smoking > or = 40 years ago" was only associated with CRC cases with APC mutations, OR = 2.0 (0.34-11.95). A case-case comparison revealed similar findings for this parameter, OR = 2.24 (0.73-6.86). CONCLUSIONS Our data suggest an association between smoking and adenoma and CRC development. This association was strongest for cases without APC truncation mutation. This may implicate other factors in development of these tumors. The association detected between smoking and CRC cases with APC mutation was in relationship to the smoking parameter "starting smoking > or = 40 years ago", a time period long enough to proceed CRC initiation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
July 1998, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
December 1999, European journal of human genetics : EJHG,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
January 2005, International journal of cancer,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
October 2004, The Journal of pathology,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
July 2004, Carcinogenesis,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
May 1993, Gastroenterology,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
March 2000, Digestive diseases and sciences,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
July 1994, Cancer research,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
January 2008, Anticancer research,
Mona Sarebø, and Camilla F Skjelbred, and Rebecca Breistein, and Inger Marie B Lothe, and Per Chr Hagen, and Gunter Bock, and Inger-Lise Hansteen, and Elin H Kure
January 2004, International journal of cancer,
Copied contents to your clipboard!